U.S. Women’s Health Market Size & Outlook, 2023-2030
U.S. women’s health market, 2018-2030 (US$M)
Related Markets
U.S. women’s health market highlights
- The U.S. women’s health market generated a revenue of USD 16,772.1 million in 2023 and is expected to reach USD 23,554.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5% from 2024 to 2030.
- In terms of segment, contraceptives was the largest revenue generating application in 2023.
- Endometriosis & Uterine Fibroids is the most lucrative application segment registering the fastest growth during the forecast period.
Women’s health market data book summary
| Market revenue in 2023 | USD 16,772.1 million |
| Market revenue in 2030 | USD 23,554.3 million |
| Growth rate | 5% (CAGR from 2023 to 2030) |
| Largest segment | Contraceptives |
| Fastest growing segment | Endometriosis & Uterine Fibroids |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.8% of the global women’s health market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. women’s health market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 2,530.5 million by 2030.
Contraceptives was the largest segment with a revenue share of 36.16% in 2023. Horizon Databook has segmented the U.S. women’s health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.
In the U.S., women, especially in the age group of 19 to 50 years, are increasingly becoming health conscious owing to the growing incidence of chronic diseases, which is also one of the significant factors boosting the adoption of women’s health therapeutics in the country.
The increase in the population of women aged 65 and above is leading to a rise in the prevalence of medical conditions associated with aging such as osteoporosis and menopause. By 2050, the population of women aged 65 and above is expected to increase by 81%.
Moreover, increase in the number of women suffering from osteoporosis, obesity, depression, & menstrual disorders and high awareness in the target population are among the factors driving the market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women’s Health Market Scope
Women’s Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. women’s health market size, by application, 2018-2030 (US$M)
U.S. Women’s Health Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
